70 related articles for article (PubMed ID: 18192227)
1. Fibroblast growth factor 4 and its novel splice isoform have opposing effects on the maintenance of human embryonic stem cell self-renewal.
Mayshar Y; Rom E; Chumakov I; Kronman A; Yayon A; Benvenisty N
Stem Cells; 2008 Mar; 26(3):767-74. PubMed ID: 18192227
[TBL] [Abstract][Full Text] [Related]
2. Exposure of chimaeric embryos to exogenous FGF4 leads to the production of pure ESC-derived mice.
Soszyńska A; Krawczyk K; Szpila M; Winek E; Szpakowska A; Suwińska A
Theriogenology; 2024 Jul; 222():10-21. PubMed ID: 38603966
[TBL] [Abstract][Full Text] [Related]
3. Vitamin A/retinol and maintenance of pluripotency of stem cells.
Khillan JS
Nutrients; 2014 Mar; 6(3):1209-22. PubMed ID: 24662164
[TBL] [Abstract][Full Text] [Related]
4. Cell-cell communication through FGF4 generates and maintains robust proportions of differentiated cell types in embryonic stem cells.
Raina D; Bahadori A; Stanoev A; Protzek M; Koseska A; Schröter C
Development; 2021 Nov; 148(21):. PubMed ID: 34651174
[TBL] [Abstract][Full Text] [Related]
5. FGF4 protects the liver from immune-mediated injury by activating CaMKK
Huang Z; Pan T; Xu L; Shi L; Ma X; Zhou L; Wang L; Wang J; Zhu G; Chen D; Song L; Pan X; Wang X; Li X; Luo Y; Chen Y
Acta Pharm Sin B; 2024 Apr; 14(4):1605-1623. PubMed ID: 38572102
[TBL] [Abstract][Full Text] [Related]
6. SRRM2 splicing factor modulates cell fate in early development.
Carvalho S; Zea-Redondo L; Tang TCC; Stachel-Braum P; Miller D; Caldas P; Kukalev A; Diecke S; Grosswendt S; Grosso AR; Pombo A
Biol Open; 2024 Apr; 13(4):. PubMed ID: 38656788
[TBL] [Abstract][Full Text] [Related]
7. Isoform-resolved transcriptome of the human preimplantation embryo.
Torre D; Francoeur NJ; Kalma Y; Gross Carmel I; Melo BS; Deikus G; Allette K; Flohr R; Fridrikh M; Vlachos K; Madrid K; Shah H; Wang YC; Sridhar SH; Smith ML; Eliyahu E; Azem F; Amir H; Mayshar Y; Marazzi I; Guccione E; Schadt E; Ben-Yosef D; Sebra R
Nat Commun; 2023 Oct; 14(1):6902. PubMed ID: 37903791
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Structural and Functional Diversity among FGF Signals: A Comparative Study of Human, Mouse, and Xenopus FGF Ligands in Embryonic Development and Cancer Pathogenesis.
Goutam RS; Kumar V; Lee U; Kim J
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108717
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Transcriptome Analysis Reveals Sex-Specific Alternative Splicing Events in Zebrafish Gonads.
Lin X; Liu F; Meng K; Liu H; Zhao Y; Chen Y; Hu W; Luo D
Life (Basel); 2022 Sep; 12(9):. PubMed ID: 36143477
[TBL] [Abstract][Full Text] [Related]
10. Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.
Oshima K; Kato K; Ito Y; Daiko H; Nozaki I; Nakagawa S; Shibuya Y; Kojima T; Toh Y; Okada M; Hironaka S; Akiyama Y; Komatsu Y; Maejima K; Nakagawa H; Onuki R; Nagai M; Kato M; Kanato K; Kuchiba A; Nakamura K; Kitagawa Y
Cancer Sci; 2022 Mar; 113(3):1018-1027. PubMed ID: 34962019
[TBL] [Abstract][Full Text] [Related]
11. Alternative RNA splicing in stem cells and cancer stem cells: Importance of transcript-based expression analysis.
Ebrahimie E; Rahimirad S; Tahsili M; Mohammadi-Dehcheshmeh M
World J Stem Cells; 2021 Oct; 13(10):1394-1416. PubMed ID: 34786151
[TBL] [Abstract][Full Text] [Related]
12. Alternative splicing in mesenchymal stem cell differentiation.
Park JW; Fu S; Huang B; Xu RH
Stem Cells; 2020 Oct; 38(10):1229-1240. PubMed ID: 32627865
[TBL] [Abstract][Full Text] [Related]
13. Profiling and quantification of pluripotency reprogramming reveal that WNT pathways and cell morphology have to be reprogramed extensively.
Hu K; Ianov L; Crossman D
Heliyon; 2020 May; 6(5):e04035. PubMed ID: 32490244
[TBL] [Abstract][Full Text] [Related]
14. FGF Signaling Pathway: A Key Regulator of Stem Cell Pluripotency.
Mossahebi-Mohammadi M; Quan M; Zhang JS; Li X
Front Cell Dev Biol; 2020; 8():79. PubMed ID: 32133359
[TBL] [Abstract][Full Text] [Related]
15. An Intricate Connection between Alternative Splicing and Phenotypic Plasticity in Development and Cancer.
Biamonti G; Infantino L; Gaglio D; Amato A
Cells; 2019 Dec; 9(1):. PubMed ID: 31877720
[TBL] [Abstract][Full Text] [Related]
16. Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.
Urbini M; Indio V; Tarantino G; Ravegnini G; Angelini S; Nannini M; Saponara M; Santini D; Ceccarelli C; Fiorentino M; Vincenzi B; Fumagalli E; Casali PG; Grignani G; Pession A; Ardizzoni A; Astolfi A; Pantaleo MA
Genes Chromosomes Cancer; 2019 Sep; 58(9):636-642. PubMed ID: 30887595
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing links histone modifications to stem cell fate decision.
Xu Y; Zhao W; Olson SD; Prabhakara KS; Zhou X
Genome Biol; 2018 Sep; 19(1):133. PubMed ID: 30217220
[TBL] [Abstract][Full Text] [Related]
18. TCF3 alternative splicing controlled by hnRNP H/F regulates E-cadherin expression and hESC pluripotency.
Yamazaki T; Liu L; Lazarev D; Al-Zain A; Fomin V; Yeung PL; Chambers SM; Lu CW; Studer L; Manley JL
Genes Dev; 2018 Sep; 32(17-18):1161-1174. PubMed ID: 30115631
[TBL] [Abstract][Full Text] [Related]
19. Network Features and Dynamical Landscape of Naive and Primed Pluripotency.
Pfeuty B; Kress C; Pain B
Biophys J; 2018 Jan; 114(1):237-248. PubMed ID: 29320691
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing acting as a bridge in evolution.
Zhou K; Salamov A; Kuo A; Aerts AL; Kong X; Grigoriev IV
Stem Cell Investig; 2015; 2():19. PubMed ID: 27358887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
